iobiosciences产品代理
iobiosciences产品代理
GEMS™ 技术用于使用源自专有多能干细胞的通用 NK 细胞开发临床现成的肿瘤细胞疗法。
iO BiO Sciences 技术也适用于在稳定的哺乳动物细胞系中生物制造蛋白质或病毒载体，将生产细胞系转化为只有一个变量的即插即用制造系统：目标基因。
使用源自独特干源并具有灵活性、有效性和大规模生产性的现成自然杀伤细胞，促进细胞疗法的快速开发，以对抗癌症。
iO BiO 专注于开发自然杀伤细胞疗法来对抗癌症，最初专注于肝癌。我们的多部分系统允许灵活的治疗开发和许可机会。
iO BiO Sciences developed a novel, proprietary, genetic cell modification technology (GEMS™), allowing efficient, plug-and-play, manufacturing of Advanced Therapy Medicinal Products and Biomolecule Manufacturing.
The GEMS™ technology is used to develop clinical off-the-shelf cell therapies in oncology using a universal NK cell derived from a proprietary pluripotent stem cell.
iO BiO Sciences technology is also applicable to biomanufacturing of proteins or viral vectors in stable mammalian cell lines converting producer cell lines into a plug-and-play manufacturing systems with only one variable: the gene of interest.
Enable the rapid development of cell therapies to fight cancer using off-the-shelf natural killer cells derived from a unique stem source and engineered for flexibility, efficacy, and mass production.
iO BiO is focused on developing Natural Killer Cell therapies to fight cancers, initially focused on liver cancer. Our multi-part system allows for flexible therapy development and license opportunities.
